title: Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption.
abstract: Ovariectomy results in cancellous osteopenia in rat long bones, a condition that is prevented by treatment with estrogens. The purpose of these studies was to clarify the effects of estrogen on cancellous bone turnover using dynamic bone histomorphometry. Treatment of ovariectomized rats with diethylstilbestrol (DES) reduced the mineral apposition rate, double-label perimeter, osteoblast number, and osteoclast number, suggesting that the hormone had inhibitory effects on bone formation as well as bone resorption. However, we could not estimate the bone formation rate because of rapid resorption of tetracycline-labeled bone in the ovariectomized rat. The magnitude of loss was documented by a time course study: 58% of the tetracycline initially incorporated into the secondary spongiosa of the tibial metaphysis was resorbed after 11 days and 89% was resorbed after 22 days. Similarly, cancellous bone area was decreased by 67% after 11 days and by 88% after 22 days. Administration of either DES or tamoxifen (TAM) dramatically reduced resorption of tetracycline as well as the decrease in cancellous bone area. These results demonstrate that (1) estrogen prevents osteopenia in ovariectomized (OVX) rats, in part by inhibiting bone turnover, (2) TAM is an estrogen agonist on bone resorption, and (3) resorption of tetracycline-labeled bone leads to serious underestimation of the bone formation rate in OVX rats.
authors.affiliation: Department of Orthopedic Surgery, Mayo Foundation, Graduate School of Medicine, Rochester, Minnesota.
authors.forename: R T
authors.initials: RT
authors.lastname: Turner
authors.forename: G L
authors.initials: GL
authors.lastname: Evans
authors.forename: G K
authors.initials: GK
authors.lastname: Wakley
mesh_terms: D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001851:Bone Diseases, Metabolic / Q000517:prevention & control; D001842:Bone and Bones / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D002452:Cell Count / Q000187:drug effects; D004054:Diethylstilbestrol / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D010052:Ovariectomy; D051381:Rats; D013629:Tamoxifen / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
chemical_list: D013629:Tamoxifen; D004054:Diethylstilbestrol; D013752:Tetracycline